Company name
2022Founder
Xiling Shen leads cancer research at MD Anderson, using AI, multiomics and experimental models to study precision therapies, metastasis and the gut–brain axis. They were a 2000 Mayfield Fellow at Stanford.
Founder and CEO
Postdoctoral Fellow, Bioengineering
RF Designer
Design Engineer
Fellow